Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: A gene expression study in hypopituitary men

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages

  Zhao, Jing Ting ^a   Cowley, Mark J ^a   Lee, Paul ^a   Birzniece, Vita ^a   Kaplan, Warren ^a   Ho, Ken K Y ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CELL DEATH INDUCING DFFA LIKE EFFECTOR A; CELL PROTEIN; DIACYLGLYCEROL; FAT DROPLET; FATTY ACID; GROWTH HORMONE; HORMONE SENSITIVE LIPASE; HYDROCORTISONE; LIPID; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 PROTEIN; PHOSPHOLIPASE; RNA; SOMATOMEDIN C; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FATTY ACID BLOOD LEVEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; GROWTH HORMONE DEFICIENCY; GROWTH INHIBITION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPOPITUITARISM; INFLAMMATION; LIPID HYDROLYSIS; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LIPOGENESIS; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

ADIPOSE TISSUE; ADULT; AGED; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LIPID METABOLISM; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 79960089146     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2679     Document Type: Article

References (40)

1. Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P 2004 Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89:2192-2199 (Pubitemid 38619852)
2. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC 2003 Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults. Eur J Endocrinol 149:511-519 (Pubitemid 38054694)
3. Nielsen S, Møller N, Christiansen JS, Jørgensen JO 2001 Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50:2301-2308 (Pubitemid 33641915)
4. Johansen T, Richelsen B, Hansen HS, Din N, Malmlöf K 2003 Growth hormone-mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets. Horm Metab Res 35:243-250 (Pubitemid 36754201)
5. Ng FM, Jiang WJ, Gianello R, Pitt S, Roupas P 2000 Molecular and cellular actions of a structural domain of human growth hormone (AOD9401) on lipid metabolism in Zucker fatty rats. J Mol Endocrinol 25:287-298 (Pubitemid 32059302)
6. Khalfallah Y, Sassolas G, Borson-Chazot F, Vega N, Vidal H 2001 Expression of insulin target genes in skeletal muscle and adipose tissue in adult patients with growth hormone deficiency: effect of one year recombinant human growth hormone therapy. J Endocrinol 171:285-292 (Pubitemid 33061705)
7. Wabitsch M, Braun S, Hauner H, Heinze E, Ilondo MM, Shymko R, De Meyts P, Teller WM 1996 Mitogenic and antiadipogenic properties of human growth hormone in differentiating human adipocyte precursor cells in primary culture. Pediatr Res 40:450-456 (Pubitemid 26282580)
8. Wabitsch M, Heinze E, Hauner H, Shymko RM, Teller WM, De Meyts P, Ilondo MM 1996 Biological effects of human growth hormone in rat adipocyte precursor cells and newly differentiated adipocytes in primary culture. Metabolism 45:34-42 (Pubitemid 26104265)
9. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK 2005 Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289:E266-E271 (Pubitemid 41076627)
10. Mitchell CJ, Nelson AE, Cowley MJ, Kaplan W, Stone G, Sutton SK, Lau A, Lee CM, Ho KK 2009 Detection of growth hormone doping by gene expression profiling of peripheral blood. J Clin Endocrinol Metab 94:4703-4709
11. Smyth GK 2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3
12. Storey JD, Tibshirani R 2003 Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100:9440-9445 (Pubitemid 37033947)
13. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550 (Pubitemid 41528093)
14. Sadowski CL, Wheeler TT, Wang LH, Sadowski HB 2001 GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology 142:3890-3900 (Pubitemid 32802661)
15. Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Møller N, Lund S, Jørgensen JO 2008 Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J Clin Endocrinol Metab 93:2842-2850 (Pubitemid 352008560)
16. Huang Y, He S, Li JZ, Seo YK, Osborne TF, Cohen JC, Hobbs HH 2010 A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci USA 107:7892-7897
17. Kienesberger PC, Oberer M, Lass A, Zechner R 2009 Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions. J Lipid Res 50(Suppl):S63-S68
18. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ 2006 Characterization of the human patatin-like phospholipase family. J Lipid Res 47:1940-1949 (Pubitemid 44401981)
19. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW 2004 Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279:48968-48975 (Pubitemid 39625778)
20. Lake AC, Sun Y, Li JL, Kim JE, Johnson JW, Li D, Revett T, Shih HH, Liu W, Paulsen JE, Gimeno RE 2005 Expression, regulation, and triglyceride hydrolase activity of adiponutrin family members. J Lipid Res 46:2477-2487 (Pubitemid 41532536)
21. Nordström EA, Rydén M, Backlund EC, Dahlman I, Kaaman M, Blomqvist L, Cannon B, Nedergaard J, Arner P 2005 A humanspecific role of cell death-inducing DFFA (DNA fragmentation factor- α)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes 54:1726-1734 (Pubitemid 40770763)
22. Gummesson A, Jernås M, Svensson PA, Larsson I, Glad CA, Schéle E, Gripeteg L, Sjöholm K, Lystig TC, Sjöström L, Carlsson B, Fagerberg B, Carlsson LM 2007 Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies. J Clin Endocrinol Metab 92:4759-4765 (Pubitemid 350223457)
23. Puri V, Virbasius JV, Guilherme A, Czech MP 2008 RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27. Acta Physiol (Oxf) 192:103-115
24. Puri V, Ranjit S, Konda S, Nicoloro SM, Straubhaar J, Chawla A, Chouinard M, Lin C, Burkart A, Corvera S, Perugini RA, Czech MP 2008 Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA 105:7833-7838 (Pubitemid 351872724)
25. Zhou Z, Yon Toh S, Chen Z, Guo K, Ng CP, Ponniah S, Lin SC, Hong W, Li P 2003 Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 35:49-56 (Pubitemid 37048595)
26. Johnson RM, Napier MA, Cronin MJ, King KL 1990 Growth hormone stimulates the formation of sn-1,2-diacylglycerol in rat hepatocytes. Endocrinology 127:2099-2103 (Pubitemid 20381735)
27. Catalioto RM, Ailhaud G, Negrel R 1990 Diacylglycerol production induced by growth hormone in Ob1771 preadipocytes arises from phosphatidylcholine breakdown. Biochem Biophys Res Commun 173:840-848
28. Gibney J, Healy ML, Stolinski M, Bowes SB, Pentecost C, Breen L, McMillan C, Russell-Jones DL, Sonksen PH, Umpleby AM 2003 Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults. J Clin Endocrinol Metab 88:1792-1797 (Pubitemid 36623406)
29. Paulsen SK, Pedersen SB, Jørgensen JO, Fisker S, Christiansen JS, Flyvbjerg A, Richelsen B 2006 Growth hormone (GH) substitution in GH-deficient patients inhibits 11β-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab 91:1093-1098 (Pubitemid 43357786)
30. Bujalska IJ, Kumar S, Hewison M, Stewart PM 1999 Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase. Endocrinology 140:3188-3196 (Pubitemid 30650636)
31. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213
32. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001Atransgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
33. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR 2004 Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938 (Pubitemid 38436604)
34. Sandeep TC, Andrew R, Homer NZ, Andrews RC, Smith K, Walker BR 2005 Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54:872-879 (Pubitemid 40322093)
35. Wake DJ, Rask E, Livingstone DE, Söderberg S, Olsson T, Walker BR2003 Local and systemic impact of transcriptional up-regulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 88:3983-3988
36. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre- Millo M, Poitou C, Basdevant A, Stich V, Viguerie N, Langin D, Bedossa P, Zucker JD, Clement K 2008 Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9:R14
37. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A 2000 Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111-122 (Pubitemid 30490411)
38. Franco C, Andersson B, Lönn L, Bengtsson BA, Svensson J, Johannsson G 2007 Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial. J Clin Endocrinol Metab 92:2644-2647 (Pubitemid 47037370)
39. Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze- Mosgau S, Stallmach A, Kinne RW, Wolf G 2009 TGF-β and fibrosis in different organs: molecular pathway imprints. Biochim Biophys Acta 1792:746-756
40. Richelsen B, Pedersen SB, Børglum JD, Møller-Pedersen T, Jørgensen J, Jørgensen JO 1994 Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am J Physiol 266:E211-E216